SC Filed 2024-10-07 Event — SEC 0001193125-24-233941 →

Apeiron Investment Group Ltd. → BIONOMICS LIMITED/FI NEUP

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 2/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Filer track record (3 filings): 0% 90d win rate, +0.0% 90d edge

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

4 transactions

4 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

11 filings by this filer

10 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

6,429 shares short · -67.9% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-01-20	Wilson David Ian	director	Award	8,537	—	—
2026-01-20	Davies Peter Miles Winston	director	Award	8,537	—	—
2026-01-20	Fisher Alan	director	Award	17,073	—	—
2026-01-20	Ryan Jane	director	Award	8,537	—	—

Other 13D/G Filings on BIONOMICS LIMITED/FI

Filed	Form	Filer	Stake	Shares
2026-10-05	SCHEDULE 13G	AdvisorShares Trust	—	—	view →
2025-12-29	SCHEDULE	Lynx1 Capital Management LP	16.30%	875,328	view →
2025-01-28	SCHEDULE	Apeiron Investment Group Ltd.	4.50%	72,618	view →

Other Filings by Apeiron Investment Group Ltd.

Filed	Form	Issuer	Stake	Shares
2026-09-21	SCHEDULE 13D/A	Enhanced Group Inc.	34.30%	48,697,705	view →
2026-09-14	SCHEDULE 13D/A	AtaiBeckley Inc.	—	0	view →
2026-08-20	SCHEDULE 13D/A	Enhanced Group Inc.	31.50%	42,304,838	view →
2026-07-24	SCHEDULE 13D/A	Enhanced Group Inc.	26.60%	35,945,876	view →
2026-07-17	SCHEDULE 13D/A	AtaiBeckley Inc.	15.40%	55,770,948	view →
2026-06-16	SCHEDULE 13D/A	Enhanced Group Inc. ENHA	24.40%	29,904,746	view →
2026-05-14	SCHEDULE 13D	Enhanced Group Inc. ENHA	24.40%	29,904,746	view →
2025-01-28	SCHEDULE	Neuphoria Therapeutics Inc. NEUP	4.50%	72,618	view →
2023-05-23	SC	Sensei Biotherapeutics, Inc. SNSE	—	—	view →
2022-11-21	SC	Sensei Biotherapeutics, Inc. SNSE	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →